102 related articles for article (PubMed ID: 2565969)
1. Doxorubicin is a potent inhibitor of interleukin 1 induced cartilage proteoglycan resorption in-vitro.
Rainsford KD
J Pharm Pharmacol; 1989 Jan; 41(1):60-3. PubMed ID: 2565969
[TBL] [Abstract][Full Text] [Related]
2. Effects of anti-inflammatory drugs and agents that modify intracellular transduction signals or metabolic activities in inflammatory cells on interleukin-1 induced cartilage proteoglycan resorption in vitro.
Rainsford KD
Pharmacol Res; 1992; 25(4):335-46. PubMed ID: 1329061
[TBL] [Abstract][Full Text] [Related]
3. Effects of anti-inflammatory drugs on interleukin 1-induced cartilage proteoglycan resorption in-vitro: inhibition by aurothiophosphines but no influence from perturbed eicosanoid metabolism.
Rainsford KD
J Pharm Pharmacol; 1989 Feb; 41(2):112-7. PubMed ID: 2568418
[TBL] [Abstract][Full Text] [Related]
4. Effects of antimalarial drugs on interleukin 1-induced cartilage proteoglycan degradation in-vitro.
Rainsford KD
J Pharm Pharmacol; 1986 Nov; 38(11):829-33. PubMed ID: 2879013
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1: purification and biochemical aspects of its action on cartilage.
Saklatvala J
J Rheumatol; 1987 May; 14 Spec No():52-4. PubMed ID: 3498042
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage.
Saklatvala J
Nature; 1986 Aug 7-13; 322(6079):547-9. PubMed ID: 3736671
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of interleukin 6 and interleukin 1 on collagenase and proteoglycan production by chondrocytes.
Kandel RA; Petelycky M; Dinarello CA; Minden M; Pritzker KP; Cruz TF
J Rheumatol; 1990 Jul; 17(7):953-7. PubMed ID: 2170644
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
9. The effect of human interleukin 1 on proteoglycan metabolism in human and porcine cartilage explants.
Nietfeld JJ; Wilbrink B; Den Otter W; Huber J; Huber-Bruning O
J Rheumatol; 1990 Jun; 17(6):818-26. PubMed ID: 2388205
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cartilage proteoglycan synthesis by interleukin I.
Benton HP; Tyler JA
Biochem Biophys Res Commun; 1988 Jul; 154(1):421-8. PubMed ID: 3260778
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by cysteine endopeptidase inactivators.
Buttle DJ; Saklatvala J; Barrett AJ
Agents Actions Suppl; 1993; 39():161-5. PubMed ID: 8456627
[TBL] [Abstract][Full Text] [Related]
12. Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture.
Rainsford KD; Ying C; Smith FC
J Pharm Pharmacol; 1997 Oct; 49(10):991-8. PubMed ID: 9364409
[TBL] [Abstract][Full Text] [Related]
13. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities.
Cipolletta C; Jouzeau JY; Gegout-Pottie P; Presle N; Bordji K; Netter P; Terlain B
Br J Pharmacol; 1998 Aug; 124(8):1719-27. PubMed ID: 9756389
[TBL] [Abstract][Full Text] [Related]
14. Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo.
van Beuningen HM; van der Kraan PM; Arntz OJ; van den Berg WB
Ann Rheum Dis; 1993 Mar; 52(3):185-91. PubMed ID: 8484670
[TBL] [Abstract][Full Text] [Related]
15. Functional genomic analysis of type II IL-1beta decoy receptor: potential for gene therapy in human arthritis and inflammation.
Attur MG; Dave MN; Leung MY; Cipolletta C; Meseck M; Woo SL; Amin AR
J Immunol; 2002 Feb; 168(4):2001-10. PubMed ID: 11823537
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine.
Badger AM; Cook MN; Swift BA; Newman-Tarr TM; Gowen M; Lark M
J Pharmacol Exp Ther; 1999 Aug; 290(2):587-93. PubMed ID: 10411566
[TBL] [Abstract][Full Text] [Related]
17. Effect of ebselen on IL-1-induced alterations in cartilage metabolism.
Pratta MA; Ackerman NR; Arner EC
Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336
[TBL] [Abstract][Full Text] [Related]
18. Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown.
Kozaci LD; Brown CJ; Adcocks C; Galloway A; Hollander AP; Buttle DJ
Mol Pathol; 1998 Oct; 51(5):282-6. PubMed ID: 10193524
[TBL] [Abstract][Full Text] [Related]
19. Effect of interleukin-1 on the size distribution of cartilage proteoglycans as determined by sedimentation field flow fractionation.
Arner EC; Kirkland JJ
Biochim Biophys Acta; 1989 Oct; 993(1):100-7. PubMed ID: 2804117
[TBL] [Abstract][Full Text] [Related]
20. Effect of antiinflammatory drugs on human interleukin-1-induced cartilage degradation.
Arner EC; Darnell LR; Pratta MA; Newton RC; Ackerman NR; Galbraith W
Agents Actions; 1987 Aug; 21(3-4):334-6. PubMed ID: 3500594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
